Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Qingdao Gaoce Technology
688556
5
Aerospace Nanhu Electronic Information Technology
688552
CN Stock MarketDetailed Quotes
300294 China Resources Boya Bio-pharmaceutical Group
- 27.01
- +0.18+0.67%
Market Closed May 8 15:00 CST
13.62BMarket Cap35.45P/E (TTM)
27.06High26.71Low43.96KlotVolume26.83Open26.83Pre Close118.23MTurnover0.87%Turnover Ratio34.32P/E (Static)504.25MShares41.8252wk High1.79P/B13.62BFloat Cap26.2852wk Low32.20Limit Up504.25MShs Float57.28Historical High21.46Limit Down1.31%Amplitude3.34Historical Low0.46Dividend TTM26.90Avg Price20.78KlotAsk1.70%Div YieldTTM100Lot Size22.92KlotBid
China Resources Boya Bio-pharmaceutical Group Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 19.49%535.88M | -34.58%1.73B | -43.16%1.25B | -41.87%895.74M | -44.36%448.45M | -3.87%2.65B | 5.17%2.19B | 10.16%1.54B | 23.11%805.93M | 4.08%2.76B |
| Operating revenue | 19.49%535.88M | -34.58%1.73B | -43.16%1.25B | -41.87%895.74M | -44.36%448.45M | -3.87%2.65B | 5.17%2.19B | 10.16%1.54B | 23.11%805.93M | 4.08%2.76B |
| Other operating revenue | ---- | -6.13%794.03K | ---- | -7.47%576.89K | ---- | 138.05%845.92K | ---- | 120.05%623.44K | ---- | -142.70%-2.22M |
| Total operating cost | 36.04%409.83M | -38.72%1.28B | -51.21%853.44M | -51.85%590.06M | -52.53%301.27M | -6.07%2.09B | 6.17%1.75B | 12.15%1.23B | 22.64%634.66M | 2.41%2.22B |
| Operating cost | 71.38%247.57M | -51.05%613.21M | -62.07%415.05M | -61.74%295.36M | -65.93%144.46M | 0.16%1.25B | 16.92%1.09B | 21.69%772.07M | 42.64%424.06M | 9.71%1.25B |
| Operating tax surcharges | 30.71%5.25M | -7.92%18.48M | -17.43%12.96M | -25.25%8.02M | -29.07%4.02M | -8.43%20.07M | -6.11%15.7M | 3.03%10.73M | 16.30%5.66M | 9.67%21.92M |
| Operating expense | -4.04%99.84M | -27.98%419.59M | -39.71%273.79M | -39.81%192.73M | -34.36%104.04M | -16.23%582.59M | -12.33%454.12M | -5.47%320.21M | -4.73%158.5M | -9.43%695.45M |
| Administration expense | 31.80%50.03M | -4.20%186.67M | -20.14%127.76M | -20.14%80.67M | -15.06%37.96M | -15.27%194.85M | 0.26%159.98M | 2.39%101.01M | -7.47%44.69M | 12.96%229.97M |
| Financial expense | 58.35%-3.42M | 16.13%-25.57M | -1.65%-23.49M | -4.35%-17.04M | 0.34%-8.21M | -20.63%-30.49M | -26.14%-23.11M | -32.30%-16.33M | -32.77%-8.23M | -22.68%-25.28M |
| -Interest expense (Financial expense) | 398.42%92.76K | 45.80%664.23K | -69.64%125.07K | -62.90%104.47K | -83.78%18.61K | -26.86%455.59K | -19.97%412K | -20.23%281.61K | -35.65%114.73K | -94.08%622.91K |
| -Interest Income (Financial expense) | 52.12%-3.96M | 5.95%-29.43M | -0.26%-23.87M | -3.36%-17.32M | 1.78%-8.27M | -19.44%-31.29M | -24.77%-23.81M | -30.01%-16.75M | -30.42%-8.42M | 16.83%-26.2M |
| Research and development | -44.40%10.57M | -1.19%66.89M | -1.38%47.38M | -19.58%30.32M | 90.36%19.01M | 36.54%67.7M | 34.85%48.04M | 65.56%37.71M | 45.32%9.98M | -16.38%49.58M |
| Credit Impairment Loss | -353.03%-7.63M | -205.08%-7.5M | -303.88%-2.91M | -131.91%-5.83M | 53.08%-1.69M | 27.68%-2.46M | 88.39%-719.73K | 69.22%-2.51M | 38.86%-3.59M | 45.00%-3.4M |
| Asset Impairment Loss | -133.44%-220.82K | 74.57%-83.83M | 880.67%628.57K | -201.27%-196.48K | 842.73%660.31K | -526.62%-329.66M | -93.10%64.1K | -70.51%194.02K | -56.44%70.04K | 34.82%-52.61M |
| Other net revenue | 32.02%36.39M | 110.34%21.62M | -34.76%88.64M | -24.21%60.9M | -19.30%27.56M | -5,128.21%-209.17M | 94.06%135.85M | 149.84%80.34M | 379.34%34.16M | 89.23%-4M |
| Fair value change income | 33.60%24.74M | -23.51%65.58M | -19.67%60.82M | -33.99%39.09M | -46.73%18.52M | 1,579.99%85.74M | 251.95%75.71M | 578.63%59.22M | 518.81%34.76M | -52.37%5.1M |
| Invest income | 59.54%1.9M | -6.80%13.06M | -81.17%7.81M | -3.52%6.71M | 0.22%1.19M | -63.82%14.01M | -13.88%41.49M | -85.56%6.95M | --1.19M | 19.55%38.73M |
| Asset deal income | --13.66K | -147.06%-611.75K | -163.20%-302.55K | -163.86%-125.11K | ---- | 1,798.54%1.3M | 748.63%478.75K | 101.55%195.92K | -59.27%33.35K | 107.87%68.47K |
| Other revenue | 98.12%17.59M | 59.43%34.91M | 19.96%22.59M | 30.41%21.25M | 423.10%8.88M | 170.27%21.89M | 240.53%18.83M | 332.69%16.3M | -0.31%1.7M | 8.19%8.1M |
| Operating profit | -7.05%162.44M | 34.35%477.25M | -16.78%480.3M | -7.39%366.57M | -14.93%174.75M | -33.25%355.23M | 14.24%577.18M | 17.04%395.82M | 64.46%205.42M | 20.12%532.18M |
| Add:Non operating Income | -32.88%1.07M | 81.25%6.88M | 155.77%5.99M | 586.88%5.16M | 121.58%1.59M | -31.65%3.8M | -25.68%2.34M | -70.50%750.84K | -26.75%719.4K | 74.65%5.56M |
| Less:Non operating expense | 123.33%153.81K | 20.97%6.42M | 35.77%5.87M | 30.37%3.88M | -79.80%68.87K | -7.40%5.31M | -1.27%4.32M | 64.95%2.98M | 164.55%340.88K | 83.83%5.74M |
| Total profit | -7.33%163.35M | 35.06%477.71M | -16.48%480.43M | -6.54%367.85M | -14.35%176.27M | -33.51%353.71M | 14.12%575.2M | 16.13%393.59M | 63.64%205.8M | 20.06%532M |
| Less:Income tax cost | -1.84%24.06M | -23.09%81.19M | -32.76%67.99M | -14.46%52.15M | -22.01%24.51M | 22.02%105.56M | 34.59%101.11M | 16.30%60.96M | 66.20%31.43M | 1.97%86.51M |
| Net profit | -8.22%139.29M | 59.79%396.53M | -13.01%412.43M | -5.09%315.7M | -12.97%151.76M | -44.30%248.15M | 10.54%474.09M | 16.10%332.63M | 63.19%174.37M | 24.34%445.49M |
| Net profit from continuing operation | -8.22%139.29M | 84.32%396.53M | -13.01%412.43M | -5.09%315.7M | -12.97%151.76M | -42.86%215.14M | 10.54%474.09M | 16.10%332.63M | 63.19%174.37M | 5.09%376.5M |
| Net income from discontinuing operating | ---- | ---- | ---- | ---- | ---- | -52.15%33.01M | ---- | ---- | ---- | --68.99M |
| Less:Minority Profit | 27.14%-192.38K | -104.33%-463.1K | -102.71%-271.35K | -103.99%-267.35K | -106.51%-264.04K | -19.62%10.68M | -5.63%10.02M | -12.53%6.71M | 22.97%4.06M | -3.34%13.29M |
| Net profit of parent company owners | -8.25%139.48M | 67.18%396.99M | -11.07%412.7M | -3.05%315.97M | -10.74%152.02M | -45.06%237.47M | 10.95%464.07M | 16.88%325.92M | 64.47%170.32M | 25.45%432.2M |
| Earning per share | ||||||||||
| Basic earning per share | -6.67%0.28 | 68.09%0.79 | -10.87%0.82 | -3.08%0.63 | -11.76%0.3 | -45.35%0.47 | 10.84%0.92 | 18.18%0.65 | 61.90%0.34 | 8.86%0.86 |
| Diluted earning per share | -6.67%0.28 | 68.09%0.79 | -10.87%0.82 | -3.08%0.63 | -11.76%0.3 | -45.35%0.47 | 10.84%0.92 | 18.18%0.65 | 61.90%0.34 | 8.86%0.86 |
| Other composite income | -370.42K | 2.36M | ||||||||
| Other composite income of parent company owners | ---370.42K | --2.36M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | -8.46%138.92M | 60.75%398.89M | -13.01%412.43M | -5.09%315.7M | -12.97%151.76M | -44.30%248.15M | 10.54%474.09M | 16.10%332.63M | 63.19%174.37M | 19.41%445.49M |
| Total composite income of parent company owners | -8.49%139.11M | 68.17%399.35M | -11.07%412.7M | -3.05%315.97M | -10.74%152.02M | -45.06%237.47M | 10.95%464.07M | 16.88%325.92M | 64.47%170.32M | 20.28%432.2M |
| Total composite income of minority owners | 27.14%-192.38K | -104.33%-463.1K | -102.71%-271.35K | -103.99%-267.35K | -106.51%-264.04K | -19.62%10.68M | -5.63%10.02M | -12.53%6.71M | 22.97%4.06M | -3.34%13.29M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting